# FDA Inspection 812172 - Biomat USA Inc. - January 04, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/efc7eaea-63d4-4a1a-93f4-caa58e5af153
Source feed: FDA_Inspections

> FDA Inspection 812172 for Biomat USA Inc. on January 04, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 812172
- Company Name: Biomat USA Inc.
- Inspection Date: 2013-01-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1152233 - 2021-08-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f0e0524e-561b-41b2-8569-46cba3687ba7)
- [FDA Inspection 1152233 - 2021-08-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0a4f59c0-899d-4691-81ee-7798322b17bc)
- [FDA Inspection 1001544 - 2017-02-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5bf82c26-c031-4ed2-bdc5-82914c6352bc)
- [FDA Inspection 915356 - 2015-02-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7656e5d1-31af-4bd5-bf00-526510fdc337)
- [FDA Inspection 696608 - 2010-11-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/59d7bd8b-fcb1-492c-9882-00df531b3352)

Company: https://www.keypedia.com/companies/biomat-usa-inc/8adc1508-0b61-48aa-b57c-1044487e3286

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d